Live from the NIH registry
Studies recruiting near Amarillo right now
Top 25 of 96 recruiting studies, sorted by proximity — each links to its official registry page
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Amarillo, Texas (1.6 mi)
· Sponsor: Sameek Roychowdhury
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Texas Oncology - West Texas — Amarillo, Texas (1.6 mi)
· Sponsor: Pfizer
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Malignancy
N/A
Observational 240 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Molecular Genetics Studies of Cancer Patients and Their Relatives
Malignant Neoplasm
N/A
Observational 999,999 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: City of Hope Medical Center
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Texas Tech University Health Sciences Center-Amarillo — Amarillo, Texas (1.6 mi)
· Sponsor: Children's Oncology Group
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
High-Risk Non-Muscle-Invasive Bladder Cancer
Phase 2
Interventional 325 participants sought
Amarillo Urology Research — Amarillo, Texas (1.6 mi)
· Sponsor: CG Oncology, Inc.
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Heart Failure
Phase 2
Interventional 200 participants sought
Amarillo Medical Specialists — Amarillo, Texas (1.6 mi)
· Sponsor: Novo Nordisk A/S
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
PharmaTex Research, LLC — Amarillo, Texas (1.6 mi)
· Sponsor: Amgen
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
Phase 3
Interventional 4,800 participants sought
Research Site — Amarillo, Texas (1.6 mi)
· Sponsor: AstraZeneca
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1020 — Amarillo, Texas (1.6 mi)
· Sponsor: Immunovant Sciences GmbH
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Pharmatex Research — Amarillo, Texas (1.6 mi)
· Sponsor: Boehringer Ingelheim
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
Texas Tech University Health Sciences Center-Amarillo — Amarillo, Texas (1.6 mi)
· Sponsor: Children's Oncology Group
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
Obesity, Overweight
Phase 3
Interventional 2,340 participants sought
Kailera Clinical Site — Amarillo, Texas (1.6 mi)
· Sponsor: Kailera
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: Agendia
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
Texas Tech University Health Sciences Center-Amarillo-63885 — Amarillo, Texas (1.6 mi)
· Sponsor: Boehringer Ingelheim
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO)
Phase 2
Interventional 160 participants sought
Amarillo, Texas — Amarillo, Texas (1.6 mi)
· Sponsor: EyeBiotech Ltd.
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 56 participants sought
The Don and Sybil Harrington Cancer Center — Amarillo, Texas (1.6 mi)
· Sponsor: SWOG Cancer Research Network
Pelacarsen Roll-over Extension Program
Atherosclerotic Cardiovascular Disease
Phase 3
Interventional 599 participants sought
Pharma Tex Research — Amarillo, Texas (1.6 mi)
· Sponsor: Novartis Pharmaceuticals
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Amarillo, Texas (1.6 mi)
· Sponsor: Akero Therapeutics, Inc
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor
Phase 3
Interventional 1,656 participants sought
Texas Tech University Health Sciences Center-Amarillo — Amarillo, Texas (1.6 mi)
· Sponsor: Children's Oncology Group
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
Graves' Disease
Phase 2
Interventional 232 participants sought
Site 100 — Amarillo, Texas (1.6 mi)
· Sponsor: Yarrow Bioscience, Inc.
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP)
Phase 1
Interventional 144 participants sought
Amarillo Center for Clinical Research — Amarillo, Texas (1.6 mi)
· Sponsor: Chugai Pharmaceutical
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Cardiovascular Disease
Phase 3
Interventional 15,100 participants sought
Research Site — Amarillo, Texas (1.6 mi)
· Sponsor: AstraZeneca
Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol
Hypertriglyceridemia
Phase 2
Interventional 316 participants sought
Marea Site 322 — Amarillo, Texas (1.6 mi)
· Sponsor: Marea Therapeutics
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
Atrial Fibrillation (AF)
Phase 3
Interventional 2,628 participants sought
PharmaTex Research — Amarillo, Texas (1.6 mi)
· Sponsor: Regeneron Pharmaceuticals